Table 2

Network meta-analysis treatment ranking results for pain outcome analyses, for each of short-term outcomes, medium-term outcomes and long-term outcomes

TreatmentShort-term painMedium-term painLong-term pain
SUCRAMean rankSUCRAMean rankSUCRAMean rank
NSAID Inj+Exe63.33.6
Oral NSAID3.77.713.37.9
Steroid Inj79.52.463.73.958.43.9
Steroid Inj+Exe74.42.854.74.662.73.6
  • Surface under cumulative ranking curve (SUCRA) values (0 – 100) and mean ranks are presented, based on a simulation with 1000 replications. Higher SUCRA s and lower mean ranks indicate better performing treatments.

  • ESWT, extracorporeal shockwave therapy; ESWT+Exe, extracorporeal shockwave therapy combined with exercise; ESWT+Orthoses, extracorporeal shockwave therapy combined with orthoses; Exe, exercise; NSAID Inj+Exe, oral non-steroidal anti-inflammatory drug combined with exercise; Oral NSAID, oral non-steroidal anti-inflammatory drug; Orthoses, prefabricated or customised foot orthoses; Placebo, usual care/placebo; Steroid Inj, corticosteroid injection; Steroid Inj+Exe, corticosteroid injection combined with exercise.